Trial intelligence / Profile preview

Remimazolam vs propofol for effects on cardiac function during general anesthesia induction

ChiCTR2300079210Phase 4Not yet recruiting

Sponsor
The Second Affiliated Hospital of Dalian Medical University
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial comparing Propofol group with Remimazolam group (2 arms). Primary endpoints: Hemodynamic parameters during anesthesia induction, Traditional echocardiographic cardiac function parameters and 1 more. Planned start Dec 2023; status: not yet recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2300079210.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300079210.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call